Thbd Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Thbd
thrombomodulin
MGI:98736

70 phenotypes from 11 alleles in 15 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tg(Tek-cre)1Ywa/0 Thbd^tm2Rdr/Thbd^tm2Wlr involves: 129S2/SvPas * C57BL/6 * SJL	abnormal acute phase protein level	J:71269
	abnormal blood coagulation	J:71269
	abnormal liver morphology	J:71269
	abnormal lung morphology	J:71269
	abnormal placental thrombosis	J:71269
	abnormal thrombosis	J:71269
	cardiac fibrosis	J:71269
	decreased body size	J:71269
	decreased body weight	J:71269
	embryonic lethality during organogenesis, incomplete penetrance	J:71269
	enlarged heart	J:71269
	gastrointestinal hemorrhage	J:71269
	hematuria	J:71269
	hemothorax	J:71269
	increased circulating D-dimer level	J:71269
	increased circulating interleukin-6 level	J:71269
	increased heart right ventricle weight	J:71269
	increased heart weight	J:71269
	increased megakaryocyte cell number	J:71269
	increased spleen weight	J:71269
	intracerebral hemorrhage	J:71269
	lethality throughout fetal growth and development, incomplete penetrance	J:71269
	liver hemorrhage	J:71269
	lung hemorrhage	J:71269
	pallor	J:71269
	premature death	J:71269
	priapism	J:71269
	pulmonary hypertension	J:71269
	skin hemorrhage	J:71269
	slow postnatal weight gain	J:71269
	thrombocytopenia	J:71269
Thbd^{tm1(THBD)Sltz}/Thbd⁺ either: 129S/SvEv-Thbd^{tm1(THBD)Sltz} or (involves: 129S/SvEv * C57BL/6)	abnormal enzyme/coenzyme activity	J:191461
Thbd^{tm1(THBD)Sltz}/Thbd^{tm1(THBD)Sltz} 129S/SvEv-Thbd^{tm1(THBD)Sltz}	abnormal enzyme/coenzyme activity	J:191461
	preweaning lethality, incomplete penetrance	J:191461
Thbd^{tm1(THBD)Sltz}/Thbd^{tm1(THBD)Sltz} involves: 129S/SvEv * C57BL/6	abnormal enzyme/coenzyme activity	J:191461
	lethality during fetal growth through weaning, incomplete penetrance	J:191461
Thbd^{tm1.1(KOMP)Vlcg}/Thbd⁺ C57BL/6N-Thbd^{tm1.1(KOMP)Vlcg}/Ucd	increased lung weight	J:211773
Thbd^{tm1.1(KOMP)Vlcg}/Thbd^{tm1.1(KOMP)Vlcg} C57BL/6N-Thbd^{tm1.1(KOMP)Vlcg}/Ucd	embryonic lethality prior to organogenesis	J:211773
	preweaning lethality, complete penetrance	J:211773
Thbd^{tm1.1(THBD)Sltz}/Thbd⁺ either: 129S/SvEv(FVB)-Thbd^{tm1.1(THBD)Sltz} or B6.129S(FVB)-Thbd^{tm1.1(THBD)Sltz}	abnormal enzyme/coenzyme activity	J:191461
Thbd^{tm1.1(THBD)Sltz}/Thbd^{tm1.1(THBD)Sltz} 129S/SvEv(FVB)-Thbd^{tm1.1(THBD)Sltz}	abnormal enzyme/coenzyme activity	J:191461
	preweaning lethality, incomplete penetrance	J:191461
Thbd^{tm1.1(THBD)Sltz}/Thbd^{tm1.1(THBD)Sltz} B6.129S(FVB)-Thbd^{tm1.1(THBD)Sltz}	abnormal enzyme/coenzyme activity	J:191461
	abnormal response to injury	J:191461
	lethality during fetal growth through weaning, incomplete penetrance	J:191461
Thbd^tm1.1Hlwu/Thbd^tm1.1Hlwu Lyz2^tm1(cre)Ifo/Lyz2⁺ B6.129-Thbd^tm1.1Hlwu Lyz2^tm1(cre)Ifo	decreased circulating interleukin-6 level	J:188879
	decreased circulating tumor necrosis factor level	J:188879
	decreased susceptibility to bacterial infection	J:188879
	decreased susceptibility to bacterial infection induced morbidity/mortality	J:188879
	decreased susceptibility to induced morbidity/mortality	J:188879
	decreased susceptibility to injury	J:188879
	decreased tumor necrosis factor secretion	J:188879
Thbd^tm1Emc/Thbd^tm1Emc involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal circulating protein level	J:54997
	normal homeostasis/metabolism phenotype	J:54997
Thbd^tm1Rdr/Thbd⁺ involves: 129S2/SvPas	no abnormal phenotype detected	J:22630
Thbd^tm1Rdr/Thbd^tm1Rdr involves: 129S2/SvPas	abnormal embryonic tissue morphology	J:22630
	abnormal endocardium morphology	J:22630
	abnormal heart development	J:22630
	embryonic growth arrest	J:22630
	embryonic lethality during organogenesis, complete penetrance	J:22630
Thbd^tm1Wlr/Thbd^tm1Wlr B6.129S2-Thbd^tm1Wlr	abnormal blood coagulation	J:111502
	abnormal heart morphology	J:111502
	abnormal kidney morphology	J:111502
	abnormal lung morphology	J:111502
	abnormal spleen morphology	J:111502
	decreased circulating tumor necrosis factor level	J:111502
	increased circulating D-dimer level	J:111502
	increased circulating interleukin-1 beta level	J:111502
	increased circulating interleukin-6 level	J:111502
	increased susceptibility to endotoxin shock	J:111502
	increased susceptibility to induced morbidity/mortality	J:111502
	increased susceptibility to induced thrombosis	J:111502
Thbd^tm1Wlr/Thbd^tm2Rdr involves: 129S2/SvPas * C57BL/6	abnormal blood coagulation	J:111502
	abnormal heart morphology	J:47676, J:111502
	abnormal lung morphology	J:47676, J:111502
	abnormal lung thrombosis	J:47676
	abnormal spleen morphology	J:47676, J:111502
	increased circulating D-dimer level	J:111502
	increased susceptibility to induced thrombosis	J:111502
Thbd^tm2.1Emc/Thbd^tm2.1Emc involves: 129/Sv * BALB/c * C57BL/6	abnormal leukocyte adhesion	J:118000
	abnormal leukocyte physiology	J:118000
	increased circulating interleukin-1 beta level	J:118000
	increased circulating tumor necrosis factor level	J:118000
	increased myocardial infarct size	J:118000
	increased susceptibility to endotoxin shock	J:118000
Thbd^tm2Emc/Thbd^tm2Emc either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)	abnormal leukocyte physiology	J:118000
	increased susceptibility to induced morbidity/mortality	J:118000
Thbd^tm2Rdr/Thbd^tm2Rdr involves: 129S2/SvPas * C57BL/6	abnormal placenta development	J:82224
	abnormal trophoblast layer morphology	J:82224
	decreased trophoblast giant cell number	J:82224
	embryonic growth arrest	J:74855, J:82224
	embryonic lethality, complete penetrance	J:74855
	small ectoplacental cone	J:82224

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24